Massimo Amicosante, graduated at the University “La Sapienza” in 1991, he is currently assistant professor at the University of Rome “Tor Vergata”. He has a long track record in immunogenetics and immunology of infectious diseases as well as in developing immuno-informatics models applied to infectious diseases susceptibility, with particular applications to antigen recognition and the use of peptides and proteins for diagnosis and vaccine development. He has considerable experience in transfer technologies and has participated in support actions to the HIV-infected pediatric cohort of the Benghazi Children Hospital (Libya) outbreak. Massimo Amicosante, graduated at the University “La Sapienza” in 1991, he is currently assistant professor at the University of Rome “Tor Vergata”. He has a long track record in immunogenetics and immunology of infectious diseases as well as in developing immuno-informatics models applied to infectious diseases susceptibility, with particular applications to antigen recognition and the use of peptides and proteins for diagnosis and vaccine development. He has considerable experience in transfer technologies and has participated in support actions to the HIV-infected pediatric cohort of the Benghazi Children Hospital (Libya) outbreak.

Vaccine, Immunology